Arvee Laboratories (India) Balance Sheet Health
Financial Health criteria checks 6/6
Arvee Laboratories (India) has a total shareholder equity of ₹291.1M and total debt of ₹10.0M, which brings its debt-to-equity ratio to 3.4%. Its total assets and total liabilities are ₹385.6M and ₹94.5M respectively. Arvee Laboratories (India)'s EBIT is ₹15.0M making its interest coverage ratio 6. It has cash and short-term investments of ₹75.4M.
Key information
3.4%
Debt to equity ratio
₹10.00m
Debt
| Interest coverage ratio | 6x |
| Cash | ₹75.40m |
| Equity | ₹291.14m |
| Total liabilities | ₹94.49m |
| Total assets | ₹385.63m |
Recent financial health updates
No updates
Recent updates
Here's Why We Think Arvee Laboratories (India) (NSE:ARVEE) Might Deserve Your Attention Today
Aug 08
Here's Why We Think Arvee Laboratories (India) (NSE:ARVEE) Is Well Worth Watching
Apr 13Do Arvee Laboratories (India)'s (NSE:ARVEE) Earnings Warrant Your Attention?
Dec 22We Ran A Stock Scan For Earnings Growth And Arvee Laboratories (India) (NSE:ARVEE) Passed With Ease
Sep 16Subdued Growth No Barrier To Arvee Laboratories (India) Ltd.'s (NSE:ARVEE) Price
Aug 13Calculating The Intrinsic Value Of Arvee Laboratories (India) Ltd. (NSE:ARVEE)
Apr 19Financial Position Analysis
Short Term Liabilities: ARVEE's short term assets (₹227.0M) exceed its short term liabilities (₹73.1M).
Long Term Liabilities: ARVEE's short term assets (₹227.0M) exceed its long term liabilities (₹21.4M).
Debt to Equity History and Analysis
Debt Level: ARVEE has more cash than its total debt.
Reducing Debt: ARVEE's debt to equity ratio has reduced from 78.2% to 3.4% over the past 5 years.
Debt Coverage: ARVEE's debt is well covered by operating cash flow (670.8%).
Interest Coverage: ARVEE's interest payments on its debt are well covered by EBIT (6x coverage).